The Auto Channel
The Largest Independent Automotive Research Resource
The Largest Independent Automotive Research Resource
Official Website of the New Car Buyer

Amerigon Reports 4th Quarter, Full Year Results

3 February 1999

Amerigon Reports 4th Quarter, Full Year Results; Company Achieves Production Preparation Milestones


    IRWINDALE, Calif.--Feb. 2, 1999--


    Q4 Highlights
    -- Selected by three European automakers to engineer the CCS(tm)
    system into their seats for a possible launch in the 2001 and
    2002 model years.
    -- Continues negotiations with U.S. and foreign automakers
    regarding potential orders for the CCS(tm) system.
    -- The New Mexico State Highway and Transportation Department
    approves Phase III trials of AmeriGuard(tm) Radar System in
    New Mexico.
    -- Appoints New York-based Spencer Trask Securities as its
    investment banker.


    Amerigon Incorporated , a development stage company, today reported results for the fourth quarter and year ended December 31, 1998. The Company effected a one-for-five reverse stock split on January 26, 1999. All references to earnings per share in this press release are to pre-split numbers.
    Revenues generated in the fourth quarter of 1998 totaled $122,000, down from $162,000 a year earlier. Losses totaled $2.46 million, or 26 cents per share, compared to losses of $1.78 million, or 19 cents per share, a year earlier.
    For the year, the Company posted revenue of $770,000, down from $1.31 million in 1998. For the year, Amerigon reported a net loss of $7.71 million, or 81 cents per share, up from $5.42 million, or 62 cents per share.
    Commenting on the fourth quarter, Amerigon President and Chief Operating Officer Richard A. Weisbart said, "Results for the quarter and year were in line with management's expectations. During the quarter, we continued to invest heavily in our proprietary Climate Control Seat(tm) System and our proprietary AmeriGuard(tm) Radar System. We believe this investment is warranted as evidenced by the interest shown by the world's leading automakers."
    The Company announced in November that it had been engaged by three leading European automotive companies to integrate the CCS(tm) system into their seats for a possible launch in the 2001 and 2002 model years. The CCS(tm) system is the world's first active temperature control system for motor vehicle seats, offering heating, cooling and ventilation.
    In October, the Company announced that Johnson Controls, Inc. had selected Amerigon to supply the CCS(tm) system to be installed in seat platforms of a major North American auto manufacturer, starting in the 2000 model year. That program is continuing to advance as expected.
    Amerigon also announced that the New Mexico State Highway and Transportation Department (NMSHTD) has approved Phase III trials of AmeriGuard(tm), the patented backup warning system that places radar technology in the rear reflector and rear turn signal light, alerting operators of potential obstacles. "Based upon the results achieved in New Mexico, we believe that other states and private companies will want to acquire the product in an effort to improve the safety of their heavy equipment fleets," Weisbart said.
    The appointment in November of New York-based Spencer Trask Securities was designed to enhance the Company's access to financial markets and strategic investments, helping with its transition into a production entity. Spencer Trask specializes in working with emerging growth companies by providing advisory services relating to strategic planning and business development, as well as financing and traditional investment banking functions.
    Amerigon, an emerging player in the global automotive industry, develops and markets proprietary high-technology products for the automotive OEM. In addition to the CCS(tm) system, the Company's products include its proprietary AmeriGuard(tm) Radar System to extend the driver's field of view in such vehicle applications as enhanced parking aids, backup warning systems, and side object detection.


    This release contains forward-looking statements (within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties. Such statements may be identified by the use of forward-looking terminology such as "may," "will," "expect," "believe," "estimate," "anticipate," "continue," or similar terms, variations of such terms or the negative of such terms. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements, including, without limitation, demand for the Company's products, consumer acceptance and performance of the Company's products, uncertainty in the development of high-technology products, the Company's ability to obtain additional financing, risks and delays in obtaining customer orders, technological change, competition and other risks and uncertainties that are detailed in the Company's Annual Report on Form 10K and other reports filed by it with the Securities and Exchange Commission.
                        AMERIGON INCORPORATED
                   (A Development Stage Enterprise)

                       STATEMENTS OF OPERATIONS
                (In thousands, except per share data)
                             (Unaudited)
                                                             From
                                                        April 23, 1991
               Three Months Ended    Twelve Months Ended  (inception)
                   December 31,          December 31,   to December 31,
                 1997       1998       1997       1998       1998
Revenues:
 Product           $-         $-         $-        $18        $18
 Development 
  contracts and
  related grants  147        122      1,281        752     17,963
 Grants            15          -         27          -      6,183
  Total revenues  162        122      1,308        770     24,164
Costs and expenses:
 Product            -          -          -         24         24
 Direct development 
  contract and
  related grant 
  costs           162          -      2,586          -     20,904
 Direct grant 
  costs            (3)         -         25          -      4,757
 Research and 
  development     769      1,328      2,072      4,598     15,458
 Selling, general 
  and administrative,
  including 
  reimbursable 
  expenses      1,191      1,273      4,471      4,128     22,386
  Total costs and 
   expenses     2,119      2,601      9,154      8,750     63,529
Operating loss (1,957)    (2,479)    (7,846)    (7,980)   (39,365)
Interest income   177         30        477        251      1,294
Interest expense    -        (10)       (71)       (10)      (292)
Gain on disposal 
 of assets          -          -      2,363         33      2,396
Net income 
 (loss) before 
 extraordinary 
 items        ($1,780)   ($2,459)   ($5,077)   ($7,706)  ($35,967)
Extraordinary 
 loss from 
 extinguishment
 of indebtedness    -          -       (340)         -       (340)
Net income 
 (loss) before 
 extraordinary 
 items        ($1,780)   ($2,459)   ($5,417)   ($7,706)  ($36,307)
Basic and 
 diluted net 
 income (loss) 
 per share before 
 extraordinary 
 item          ($0.19)    ($0.26)    ($0.58)    ($0.81)
Basic and 
 diluted net 
 income (loss)
 per share     ($0.19)    ($0.26)    ($0.62)    ($0.81)
Weighted average 
 number of shares 
 outstanding    9,543      9,550      8,796      9,550